Rydapt has been shown to enhance survival in patients with AML affiliated with an FLT3 mutation. Just one major review, involving 717 these kinds of clients, when compared Rydapt with placebo (a dummy remedy) at first as an addition to other most cancers medicines, followed by treatment with Rydapt or placebo alone in Those people whose ailment res